Multiple Sclerosis Trial, Recruiting NCT06820125 Sponsor: Universita di Verona Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06820125
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have mild or severe cognitive impairment, measured by scoring below a certain threshold on one or more memory and thinking tests
  • People who have mild to moderate difficulty walking, based on a disability rating scale score between 3 and 6 (confirm with trial site)
  • People who have not had a relapse or taken steroid medication in the past three months
  • People who have adequate vision and hearing to use computer software

Who may not be able to join:

  • People who have a neurological condition other than MS
  • People who have a significant psychiatric disorder
  • People who have high levels of anxiety or depression, based on scores above certain thresholds on a specific mood questionnaire (confirm with trial site)
  • People who have a substance abuse problem
  • People who have taken part in any rehabilitation program in the month before joining the trial
  • People whose medication has not been clearly established or has recently been changed during the study period
  • People who experience episodes of sudden, intense dizziness (paroxysmal vertigo)
  • People who have had botulinum toxin injections in their legs within the previous 12 weeks

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 045 8124956

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universita di Verona
Registry
ClinicalTrials.gov
Start date
5 July 2023
Est. completion
5 July 2023

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Symbol Digit Modalities Test; 2-minute walking test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov